FDA Adverse Event Injury Summary report: N

GORE TEX® VASCULAR GRAFT

MDR report key: 3831602 · Received May 26, 2014

Report

Report Number
2017233-2014-00273
Event Type
Injury
Date Received
May 26, 2014
Date of Event
January 1, 2014
Report Date
April 28, 2014
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
DSY
PMA / PMN Number
K802095
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NO FURTHER INFORMATION IS AVAILABLE.

Description of Event or Problem · 1

IN REVIEW OF PUBLISHED LITERATURE, THESE FINDINGS WERE NOTED: MIN BAO, PH.D., HONGYIN LI, M.D., GUANGYU PAN, M.D., ZHONGHUA XU, M.D. AND QINGYU WU, M.D., "CENTRAL SHUNT PROCEDURES FOR COMPLEX CONGENITAL HEART DISEASES", J CARD SURG 2014;XX:1-5 PUBLISHED ONLINE 2014, DOI: 10.1111/JOCS.12343. BETWEEN APRIL 2004 AND NOVEMBER 2012, TOTAL 110 PATIENTS (MEDIAN AGE,11 MONTHS; MEDIAN WEIGHT, 9 KG) WITH THE COMPLEX CONGENITAL HEART DISEASES WERE TREATED WITH THE GORE-TEX GRAFTS IN THE SHUNT OPERATION, THE GRAFT SIZE WAS DETERMINED PRIMARILY BASED ON THE PATIENTS' BODY WEIGHT PRIOR TO THE OPERATIONS. THE ARTICLE DESCRIBES ONE PATIENT DEVELOPED A SHUNT OCCLUSION REQUIRING A SECOND OPERATION AT DAY 5 FOLLOWING WHICH THE PATIENT EXPERIENCED CONTINUOUS RIGHT LUNG HEMORRHAGE AND DIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
309943 GORE TEX® VASCULAR GRAFT PROSTHESIS, VASCULAR GRAFT DSY W.L. GORE & ASSOCIATES

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention